Sclerosing odontogenic carcinoma (SOC) was first described by Koutlas . in 2008. Despite its inclusion in the World Health Organization (WHO) as a distinct entity, it is a tumour that remains poorly defined in the literature, with only 10 reported cases to date. The mandibular premolar and molar region is more commonly affected compared to the maxilla. In the maxilla, the anterior and the molar regions are most commonly affected. This article describes a case report of a Sclerosing Odontogenic Carcinoma in a 50 year old male patient in the mandibular region. The radiograph showed a well-defined radiolucency extending from the left ramus of the mandible to the right lower molar region. SOC is low grade with mild atypia and frequent mitosis and diffused infiltrative and perineural spread.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11126260PMC
http://dx.doi.org/10.4103/jomfp.jomfp_128_21DOI Listing

Publication Analysis

Top Keywords

sclerosing odontogenic
12
odontogenic carcinoma
12
case report
8
molar region
8
carcinoma misnomering
4
misnomering central
4
central odontogenic
4
odontogenic fibroma-a
4
fibroma-a case
4
report review
4

Similar Publications

Sclerosing Odontogenic Carcinoma: UPLIFTS and pitfalls.

Semin Diagn Pathol

September 2024

Head of the Department, Department of oral Pathology and Microbiology, King George Medical University, Lucknow, India. Electronic address:

Sclerosing Odontogrenic Carcinoma (SOC) is a recent addition to the category of odontogenic tumours, which was first described by Koutlas et al. in 2008. It was described as primary intraosseous carcinoma with bland cytology, sclerotic stroma with presence of local infiltration showing aggressive behaviour.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic diffuse sclerosing osteomyelitis is a rare bone disease that causes jaw pain and swelling, often without previous injury or obvious causes.
  • Two case studies described patients experiencing recurrent jaw-related pain and swelling, leading to extensive diagnostic tests that confirmed the condition after excluding other factors.
  • Treatment with bisphosphonates resulted in full symptom recovery, suggesting they may be effective in managing this condition, though more research is needed to understand it better and improve treatment options.
View Article and Find Full Text PDF

Sclerosing odontogenic carcinoma (SOC) was first described by Koutlas . in 2008. Despite its inclusion in the World Health Organization (WHO) as a distinct entity, it is a tumour that remains poorly defined in the literature, with only 10 reported cases to date.

View Article and Find Full Text PDF

Rare non-odontogenic cysts of the soft tissue of the midface that form between the nasal vestibule and upper lip are known as nasolabial cysts. Treatment can be accomplished by surgical removal, injection of sclerosing material into the cyst, and endoscopic marsupialization. The aim of this study is to compare the effectiveness of Excision with sublabial approach versus Marsupialization with Transnasal Endoscopic approach in patients with Nasolabial cyst in terms of operating time, recurrence rate, postoperative pain and complications.

View Article and Find Full Text PDF

Sclerosing odontogenic carcinoma (SOC) is an exceedingly rare odontogenic carcinoma known for its locally aggressive yet indolent behavior. There have been no reports of metastasis to distant organs, except a single case involving lymph node metastasis. This report details the case of a 49-year-old female who presented with a well-demarcated radiolucent lesion in the mandible, accompanied by root resorption and tooth displacement.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!